Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo

Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial

(2010) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fondaparinux: does it cause HIT? can it treat HIT?

(2010) Theodore E Warkentin   Expert Review of Hematology

Contact activation of blood-plasma coagulation

(2009) Erwin A. Vogler et al.   BIOMATERIALS

Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes

(2008) Robert A. Harrington et al.   CHEST

Acute ST-Segment Elevation Myocardial Infarction

(2008) Shaun G. Goodman et al.   CHEST

In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus

(2008) Axel Schlitt et al.   CORONARY ARTERY DISEASE

Surfaces having dual fibrinolytic and protein resistant properties by immobilization of lysine on polyurethane through a PEG spacer

(2008) Hong Chen et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

(2008) Adnan Kastrati et al.   NEW ENGLAND JOURNAL OF MEDICINE